Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 10

乐动体育西班牙人Prostaglandins as the Agents That Modulate the Course of Brain Disorders

Authors乐动体育西班牙人 Famitafreshi H,

Received 2 December 2019乐动体育西班牙人

Accepted for publication 30 December 2019

Published乐动体育西班牙人 16 January 2020 Volume 2020:10 Pages 1—13

DOI乐动体育西班牙人

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: 乐动体育西班牙人 Prof. Dr. Thomas Müller


Hamidreza Famitafreshi, Morteza Karimian

Physiology Department, Tehran University of Medical Sciences, Tehran, Iran

Correspondence: Morteza Karimian
Department of Physiology, Tehran University of Medical Science, Enghelab St., Shanzdahazar St., Poorsina St, Tehran, Iran
Tel/Fax +98 02166419484
Email karimian@tums.ac.ir

Abstract: Neurologic and neuropsychiatric diseases are associated with great morbidity and mortality. Prostaglandins (PGs) are formed by sequential oxygenation of arachidonic acid in physiologic and pathologic conditions. For the production of PGs cyclooxygenase is a necessary enzyme that has two isoforms, that are named COX-1 and COX-2. COX-1 produces type 1 prostaglandins and on the other hand, COX-2 produces type 2 prostaglandins. Recent studies suggest PGs abnormalities are present in a variety of neurologic and psychiatric disorders. In a disease state, type 2 prostaglandins are mostly responsible and type 1 PGs are not so important in the disease state. In this review, the importance of prostaglandins especially type 2 in brain diseases has been discussed and their possible role in the initiation and outcome of brain diseases has been assessed. Overall the studies suggest prostaglandins are the agents that modulate the course of brain diseases in a positive or negative manner. Here in this review article, the various aspects of PGs in the disease state have discussed. It appears more studies must be done to understand the exact role of these agents in the pathophysiology of brain diseases. However, the suppression of prostaglandin production may confer the alleviation of some brain diseases.

Keywords: prostaglandins, depression, Alzheimer, addiction, Parkinson and multiple sclerosis


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at http://buttonshowdown.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]